Table 4.

Percentage of subjects for each treatment group reporting adverse events

Adverse event	Quetiapine (%, n)	Placebo (%, n)
Sedation	75% (15)	33.3%(7)
Dry mouth	15% (3)	0
Headache	15% (3)	38% (8)
Fatigue	15% (3)	19% (4)
Irritability	10% (2)	4.7% (1)
Impaired concentration	10% (2)	0
Dizziness	5% (1)	14.3% (3)
Nausea	5% (1)	9.5% (2)
Increased appetite	5% (1)	9.5% (2)
Delayed ejaculation	5% (1)	0
Weight gain	5% (1)	0
Worsening mood	5%(1)	4.7%(1)
Memory difficulties	5%(1)	0
Muscle aches	5%(1)	0
Abdominal tenderness	5%(1)	0
Slurred speech	5%(1)	0